Skip to main content
SCPHinactive

scPharmaceuticals Inc.

Biopharma developer (SEC filing verified)·Phase 1·CEO: Important Notice Regarding

SCPH evidence brief

What we can confirm

No verified snapshot fields are available yet.

What it means

The company data is ready for cross-source review; unsupported conclusions remain unknown.

What to watch

Watch the next source-backed data update.
BioSniper AIPage evidence connected

Prepared research question

What matters most for SCPH—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

3.0/10

BioSniper Score

Based on 4 of 6 signals

Market Cap

—

Cash Runway

9.7 mo

Lead Asset

furoscix (Phase 1)

Next Catalyst

—

Financial data as of Jun 30, 2025.

Tracking 2 pipeline candidates · 1 clinical trial for scPharmaceuticals Inc..

Run scPharmaceuticals Inc. through your own thesis

Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.

Your protocol can:

  • Turn available scPharmaceuticals Inc. facts into screen rules or deeper checks
  • Show cited findings, blockers, and unresolved evidence together
  • Save the logic and rerun it as the company evidence changes
Run a thesis on this company — freeRun a thesis on this company

Score breakdownBased on 4 of 6 signals · derived from public data

Cash Runway2.7

9.7 months

Financial Health0.5

OCF -$16M · Net income -$18M

Pipeline Maturity4.0

Lead: Phase 1

Pipeline Breadth4.6

2 candidates

Catalyst MomentumN/A

No upcoming catalysts tracked

Insider SignalN/A

No insider transactions in the last 180 days

Runway

Run my thesis on this company

Pipeline

Run my thesis on this company

Regulatory

Run my thesis on this company

Financials

Run my thesis on this company

Frequently asked questions

What is scPharmaceuticals Inc.'s lead drug candidate?

scPharmaceuticals Inc.'s most advanced tracked candidate is furoscix (Phase 1) for Congestion due to fluid overload in eligible adult patients who do not require hospitalization.

Who is the CEO of scPharmaceuticals Inc.?

Important Notice Regarding is the chief executive officer of scPharmaceuticals Inc. (SCPH).

925 companies232,681 SEC filings21,419 clinical trials100% citation-verification pass rate (7d)How we verify →

The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.